Integrated chemical profiling, network pharmacology and pharmacological evaluation to explore the potential mechanism of Xinbao pill against myocardial ischaemia–reperfusion injury

Author:

Yang Ying12,Chen Ting3,Liu Jiaming14,Chen Sixuan1,Cai Rongqing3,Wu Liqiong3,Hu Jiexiong3,Lin Qiongying3,Qi Xiaoxiao1,Liu Zhongqiu12,Cheng Yuanyuan12

Affiliation:

1. School of Pharmaceutical Sciences, Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China

2. Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou, China

3. Research and Development Department, Guangdong Xinbao Pharm-tech Co., Ltd, Guangzhou, China

4. School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, China

Funder

Key-Area Research and Development Program of Guangdong Province

Science and Technology Program of Guangzhou

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Guangdong Key Laboratory for translational Cancer research of Chinese Medicine

the National Key Research and Development Program of China

Guangdong Basic and Applied Basic Research Foundation

2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund

Publisher

Informa UK Limited

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3